88 related articles for article (PubMed ID: 2791073)
1. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
[No Abstract] [Full Text] [Related]
2. Postmarketing surveillance of adverse reactions to ProHIBit vaccine in British Columbia.
CMAJ; 1989 Nov; 141(9):927-9. PubMed ID: 2804851
[TBL] [Abstract][Full Text] [Related]
3. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
4. Haemophilus influenzae type b vaccines: lessons for the future.
Ward JI; Broome CV; Harrison LH; Shinefield H; Black S
Pediatrics; 1988 Jun; 81(6):886-93. PubMed ID: 3259307
[No Abstract] [Full Text] [Related]
5. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Granoff DM; Osterholm MT
Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
[No Abstract] [Full Text] [Related]
7. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine.
Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482
[No Abstract] [Full Text] [Related]
8. Update: Haemophilus influenzae b polysaccharide vaccine.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(9):144-5. PubMed ID: 3080673
[No Abstract] [Full Text] [Related]
9. Update: prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
[No Abstract] [Full Text] [Related]
10. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
Ward J
Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
[No Abstract] [Full Text] [Related]
11. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
[No Abstract] [Full Text] [Related]
12. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
[No Abstract] [Full Text] [Related]
13. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
[No Abstract] [Full Text] [Related]
14. The 1990s: a decade of new vaccines.
Murphy TV
Pediatr Infect Dis J; 1991 Feb; 10(2):89-91. PubMed ID: 2062619
[No Abstract] [Full Text] [Related]
15. Haemophilus influenzae diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease.
Jakacki R; Luery N; McVerry P; Lange B
Ann Intern Med; 1990 Jan; 112(2):143-4. PubMed ID: 2294819
[No Abstract] [Full Text] [Related]
16. Haemophilus influenzae type b vaccines: lessons from the past.
Daum RS; Marcuse EK; Giebink GS; Hall CB; Lepow ML; McCracken GH; Peter G; Phillips CF; Wright HT; Plotkin SA
Pediatrics; 1988 Jun; 81(6):893-7. PubMed ID: 3259308
[No Abstract] [Full Text] [Related]
17. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
[No Abstract] [Full Text] [Related]
18. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.
Weinberg GA; Granoff DM
J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001
[No Abstract] [Full Text] [Related]
19. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing.
Milstien JB; Gross TP; Kuritsky JN
Pediatrics; 1987 Aug; 80(2):270-4. PubMed ID: 3497381
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children.
Vadheim CM; Greenberg DP; Marcy SM; Froeschle J; Ward JI
Pediatr Infect Dis J; 1990 Aug; 9(8):555-61. PubMed ID: 2235171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
